• Joinn Laboratories entered three-year leases with Beijing Joinn Biologics Group, creating right-of-use assets under HKFRS 16.
• Leases run from Sept. 1, 2026 to Aug. 31, 2029 for facilities in Daxing District, Beijing.
• Right-of-use assets estimated at RMB 2.33 million, RMB 5.51 million, RMB 2.86 million; total about RMB 10.71 million.
• Annual rent totals RMB 4.08 million in 2026-27, RMB 4.09 million in 2027-28, RMB 4.08 million in 2028-29.
• Transaction classified as a fully exempt de minimis connected asset acquisition, with percentage ratios below 0.1%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Joinn Laboratories China Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260831-12307728), on August 31, 2026, and is solely responsible for the information contained therein.